Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hydrix Limited ( (AU:HYD) ) has provided an announcement.
Hydrix Limited announced a delay in the lodgement of its FY25 financial statements due to the need for an independent valuation report on its shares in Wavewise Analytics Pty Ltd. This delay will result in an automatic suspension of the company’s shares from trading on the ASX starting from October 1, 2025, until the statements are lodged, expected during the week commencing October 6, 2025.
More about Hydrix Limited
Hydrix Limited (ASX: HYD) is a product innovation company focused on enhancing health, safety, and well-being. It operates across three business segments: Services, which involves designing and engineering innovative products; Ventures, which invests in promising medtech clients; and Medical, which distributes disruptive cardiovascular products.
Average Trading Volume: 330,975
Technical Sentiment Signal: Buy
Current Market Cap: A$6.27M
Learn more about HYD stock on TipRanks’ Stock Analysis page.